2m 2m 2m 2m 2m 2m 2m
Cytodyn (CYDY)
OTC
$0.24-$0.005 (-2.12%)
Price as of Oct 22, 2026- $352.5MMarket Cap
- -5.36%1-Year Change
- BiotechnologyIndustry
Cytodyn (CYDY)
$0.24-$0.005 (-2.12%)
CYDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.24 | ||
Change | -$0.005 (-2.12%) | ||
Open | $0.25 | ||
High | $0.25 | ||
Low | $0.24 | ||
Previous Close | $0.25 | ||
Volume | 2,401,320 | ||
30-Day Average Volume | 2,174,557 | ||
1-Week Change | 16.81% | ||
1-Month Change | 16.74% | ||
1-Year Change | -5.36% | ||
3-Year Change | 53.88% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5B | ||
Total Assets | $19.1M | ||
Market Cap | $352.5M | ||
Enterprise Value | $363.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$7.7M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.9M | ||
Net Working Capital | -$30.7M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -4 | ||
P/E | -24 | ||
PEG | 1 | ||
Price/Free Cash Flow | -46 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue